Press "Enter" to skip to content

New patent for SPIL drug METOPROLOL SUCCINATE

0

Annual Drug Patent Expirations for METOPROLOL+SUCCINATE
Annual Drug Patent Expirations for METOPROLOL+SUCCINATE

Metoprolol Succinate is a drug marketed by Spil, Actavis Elizabeth, Actavis Labs Fl Inc, Dr Reddys Labs Ltd, Mylan Pharms Inc, Nesher Pharms, Novast Labs Ltd, Reddys, Sandoz, and Wockhardt and, and is included in fourteen NDAs. It is available from thirty-eight suppliers.

The generic ingredient in METOPROLOL SUCCINATE is metoprolol succinate. Thirty-eight suppliers are listed for this compound. Additional details are available on the metoprolol succinate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

Do NOT follow this link or you will be banned from the site!